A subset of advanced breast cancers are diagnosed as triple-negative breast cancer (TNBC), lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and the Her2 tyrosine kinase receptor (1, 8). This evidence concerns the gene ESR1 and breast carcinoma.